Slow binding–tight binding interaction between benzimidazol-2-one inhibitors and HIV-1 reverse transcriptase containing the lysine 103 to asparagine mutation-Reference-Cited by-同舟云学术

Slow binding–tight binding interaction between benzimidazol-2-one inhibitors and HIV-1 reverse transcriptase containing the lysine 103 to asparagine mutation

Published:2010-06 Issue:3 Volume:86 Page:268-275
ISSN:0166-3542
Container-title:Antiviral Research
language:en
Short-container-title:Antiviral Research

Author:

Samuele Alberta,Crespan Emmanuele,Vitellaro Samanta,Monforte Anna-Maria,Logoteta Patrizia,Chimirri Alba,Maga Giovanni

Publisher

Elsevier BV

Subject

Virology,Pharmacology

Reference41 articles.

1. Novel approaches to inhibiting HIV-1 replication;Adamson;Antiviral Res.,2010

2. Steady-state kinetic studies with the non-nucleoside HIV-1 reverse transcriptase inhibitor U-87201E;Althaus;J. Biol. Chem.,1993

3. Kinetic studies with the non-nucleoside HIV-1 reverse transcriptase inhibitor U-88204E;Althaus;Biochemistry,1993

4. Analysis of inhibition of retroviral reverse transcriptase;Balzarini;Methods Enzymol.,1996

5. Retention of marked sensitivity to (S)-4-isopropoxycarbonyl-6-methoxy-3-(methylthiomethyl)-3,4-di hydroquin oxaline-2(1H)-thione (HBY 097) by an azidothymidine (AZT)-resistant human immunodeficiency virus type 1 (HIV-1) strain subcultured in the combined presence of quinoxaline HBY 097 and 2′,3′-dideoxy-3′-thiacytidine (lamivudine);Balzarini;Biochem. Pharmacol.,1998

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. I2-Mediated transition-metal-free aromatic C–H amination for the synthesis of benzimidazol-2-ones and related heterocycles;New Journal of Chemistry;2018

2. 2D and 3D QSAR of Benzimidazole Analogues as Novel HIV-1 Non Nucleoside Reverse Transcriptase Inhibitors;Indian Journal of Pharmaceutical Education and Research;2017-05-01

3. Drug Discoveries and Molecular Mechanism of Action;Successful Drug Discovery;2015-01-30

4. Design and synthesis of N1-aryl-benzimidazoles 2-substituted as novel HIV-1 non-nucleoside reverse transcriptase inhibitors;Bioorganic & Medicinal Chemistry;2014-02

5. Synthesis, Biological Activity, and ADME Properties of Novel S-DABOs/N-DABOs as HIV Reverse Transcriptase Inhibitors;ChemMedChem;2012-03-14